Scripx Pharmacy & Health

Evolving the access and affordability of medications via tech and automation
Overview
Raised: $45,951
Total Commitments ($USD)
Republic
08/24/2022
01/31/2023
$25,000
$1,070,000
$100
SAFE
Pre-Seed
RegCF
$12,000,000
0%
Rolling Commitments ($USD)
02/01/2023
184%
4%
$287
107
Plano, Texas
Healthcare & Pharmaceuticals
HealthTech
B2C
Low
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$1,910,831 |
$557,891 |
COGS |
$1,928,213 |
$453,488 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-372,099 |
$-126,692 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$63,513 |
$6,579 |
Accounts Receivable |
$119,000 |
$85,476 |
Total Assets |
$940,877 |
$218,821 |
Short-Term Debt |
$333,389 |
$131,483 |
Long-Term Debt |
$761,455 |
$7,872 |
Total Liabilities |
$1,094,844 |
$139,355 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Scripx is following in the footsteps of NowRx and Capsule. It’s a Dallas-based virtual pharmacy operating within the Dallas-Fort Worth metropolitan area. Scripx offers prescription fulfillment and delivery as well as limited telehealth services. Customers can use the company’s mobile app to upload insurance documents, track their prescriptions, and order refills. But there are a few things investors should consider before investing in a duplicative company like Scripx. Rather than blazing a new trail, it’s following the drug delivery service playbook created by NowRX and Capsule. And that comes with its own mix of advantages and disadvantages.